CONMED Corporation Announces Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Conmed (CNMD) Tops Q3 EPS by 6c, Misses on Revenue; offers FY24 Guidance
October 30, 2024 4:24 PM EDTConmed (NYSE: CNMD) reported Q3 EPS of $1.05, $0.06 better than the analyst estimate of $0.99. Revenue for the quarter came in at $316.7 million versus the consensus estimate of $318.15 million.
GUIDANCE:
Conmed sees FY2024 EPS of $4.00-$4.05, versus the consensus of $3.99. Conmed sees... More
